Story
JPMorgan Upgrades Wolters Kluwer to Overweight, Citing AI Potential and Valuation
Summary
The Dutch information services company saw its shares climb nearly 4% after JPMorgan raised its rating to Overweight, highlighting the firm's strengthening 'AI moat' and a significant valuation discount to its peers.
Shares of Wolters Kluwer (WLSNc) climbed nearly 4% in Amsterdam trading after JPMorgan upgraded the Dutch information services group to Overweight from Neutral. The bank also raised its price target on the stock to €87 from €73, citing a compelling valuation and growing confidence in artificial intelligence as a key growth accelerator.
The AI Growth Thesis
JPMorgan's upgrade reflects a belief that Wolters Kluwer's investments in artificial intelligence have fortified its competitive position, or "AI moat." In a note to clients, analyst Daniel Kerven argued the company's advantage is rooted in its ownership of mission-critical workflow platforms and systems of record, where AI is expected to enhance, not replace, trusted data and processes.
The bank highlighted recent acquisitions as evidence of the company's accelerated AI roadmap, which it said reduced the risk of a slow response to AI-related threats and opportunities. Key deals include:
- Brightflag: An AI-driven legal spend management platform acquired for about €425 million in June 2025.
- Libra: A German legal AI startup purchased in January for roughly €30 million.
Valuation and Price Target
AdThe price target increase was driven by JPMorgan lowering its weighted average cost of capital (WACC) assumptions for several key divisions and raising its terminal growth rate. The new €87 target implies a 2027 price-to-earnings multiple of 12.9 times, which the bank notes is still a 20% discount to peer Pearson.
Kerven pointed out that the stock currently trades at just 9 times estimated 2027 earnings, representing a 40% discount to RELX and a 60% discount to U.S. peers. The analyst also suggested potential private equity interest, estimating a leveraged buyout could generate a base case internal rate of return of 17%, assuming a 30% takeover premium.
Market Context
The upgrade comes after a difficult period for the company's stock, which has fallen more than 55% over the past 12 months. Kerven described the move as "likely the first real WK upgrade for 18 months," noting that consensus price targets are only now adjusting to risks that have already been priced into the shares.
Despite the positive outlook, JPMorgan remains negative on the company's UpToDate clinical information unit, forecasting its organic growth will turn negative within five years due to competition from AI-native rivals. However, the bank still values the division at approximately €2.6 billion, citing its expected years of positive cash flow.